Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators

Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators

US Patent 9822130 · Granted Nov 21, 2017

Estimated economic value: $40,479,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carbamate and urea compounds as multikinase inhibitors2022
Cyclic compounds as immunomodulating agents2021
Macrocyclic compounds as TRK kinase inhibitors and uses thereof2021
Insulin dimer-incretin conjugates2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Substituted quinolizine derivatives useful as HIV integrase inhibitors2020
Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators2020